参考文献
(在框内滑动手指即可浏览)
[1] Etoh T,Ohyama T,Sakuramoto S,et al.Five-year survival outcomes of laparoscopy-assisted vs open distal gastrectomy for advanced gastric cancer: The JLSSG0901 randomized clinical trial[J].JAMA Surg,2023,158(5):445-454.
[2] 中国抗癌协会胃癌专业委员会.胃癌诊治难点中国专家共识(2020版)[J]. 中国实用外科杂志,2020,40(8):869-904.
[3] 宋武,何裕隆.晚期胃癌腹主动脉旁淋巴结转移综合治疗策略[J]. 中国实用外科杂志,2017,37(10):1102-1106.
[4] Yoshikawa T, Ando M,Mizusawa J,et al.Health-related quality-of-life results from JCOG0912: A phase III noninferiority trial comparing open and laparoscopy-assisted distal gastrectomy for stage I gastric cancer [J]. J Clin Oncol,2020,38(suppl 4):293.
[5] Kim HH,Han SU,Kim MC,et al.Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: The KLASS-01 randomized clinical trial[J].JAMA Oncol,2019,5(4):506-513.
[6] Huang C,Liu H,Hu Y,et al.Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: Five-year outcomes from the CLASS-01 randomized clinical trial[J].JAMA Surg,2022,157(1):9-17.
[7] Hayata K,Ojima T,Nakamura M,et al.Curative para-Aortic lymph node dissection Via INfra-mesocolonic approach in laparoscopic Gastrectomy (CAVING approach)[J].Langenbecks Arch Surg,2021,406(6):2067-2074.
[8] 薛玉玲,熊文俊,朱晓峰,等.治疗性腹腔镜胃癌腹主动脉旁淋巴结清扫术的操作技巧及临床意义[J]. 消化肿瘤杂志(电子版),2020,12(1):39-43.
[9] Takiguchi S,Miyazaki Y,Murakami K,et al.Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma[J].Surg Today,2016,46(9):1108-1113.
[10] Roviello F,Pedrazzani C,Marrelli D,et al.Super-extended (D3) lymphadenectomy in advanced gastric cancer[J].Eur J Surg Oncol,2010,36(5):439-446.
[11] Sasako M,Sano T,Yamamoto S,et al.D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer[J].N Engl J Med,2008,359(5):453-462.
[12] Morita S,Fukagawa T,Fujiwara H,et al.The clinical significance of para-aortic nodal dissection for advanced gastric cancer[J].Eur J Surg Oncol,2016,42(9):1448-1454.
[13] 梁寒.局部进展期胃癌合理淋巴结清扫范围再探讨[J]. 中国肿瘤临床,2016,43:(1):11-14.
[14] Sasako M,Sano T,Yamamoto S,et al.Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial[J].Lancet Oncol,2006,7(8):644-651.
[15] Park IH,Kim SY,Kim YW,et al.Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement[J].Cancer Chemother Pharmacol,2011,67(1):127-136.
[16] Yoshikawa T,Sasako M,Yamamoto S,et al.Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer[J].Br J Surg,2009,96(9):1015-1022.
[17] Tsuburaya A,Mizusawa J,Tanaka Y,et al.Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis[J].Br J Surg,2014,101(6):653-660.
[18] Ito S,Sano T,Mizusawa J,et al.A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002[J].Gastric Cancer,2017,20(2):322-331.
[19] Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition [J].Gastric Cancer,1998,1(1):10-24.
[20] 中国抗癌协会胃癌专业委员会.局部进展期胃癌规范化淋巴结清扫范围中国专家共识(2022版)[J]. 中华胃肠外科杂志,2022,25(4):277-283.
[21] Smyth EC,Verheij M,Allum W,et al.Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol,2016,27(suppl 5):v38-v49.
[22] Matsumoto T,Sasako M,Mizusawa J,et al.HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)[J].Gastric Cancer,2015,18(3):467-475.
[23] 郑民华.腹腔镜胃肠外科手术发展轨迹与趋势[J]. 中国实用外科杂志,2018,38(1):61-64.
[24] 日本胃癌学会.胃癌治療ガイドライン [M].5版. 東京:金原出版株式会社, 2018.
[25] Son SY,Hur H,Hyung WJ,et al.Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: 5-year outcomes of the KLASS-02 randomized clinical trial[J].JAMA Surg,2022,157(10):879-886.
[26] Yu J,Huang C,Sun Y,et al.Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: The CLASS-01 randomized clinical trial[J].JAMA,2019,321(20):1983-1992.
[27] Lin JX,Lin JP,Wang ZK,et al.Assessment of laparoscopic spleen-preserving hilar lymphadenectomy for advanced proximal gastric cancer without invasion into the greater curvature: A randomized clinical trial[J].JAMA Surg,2023,158(1):10-18.
[28] Son SY,Lee CM,Lee JH,et al.Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasis[J].J Korean Surg Soc,2013,84(5):304-308.
[29] 何裕隆.进展期胃癌腹主动脉旁淋巴结清扫技巧[J]. 中华消化外科杂志,2012,11(3):197-199.
[30] Nomura E,Sasako M,Yamamoto S,et al.Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501[J].Jpn J Clin Oncol,2007,37(6):429-433.